Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jan 16;83(2):291-299.
doi: 10.1016/j.jacc.2023.10.034.

Rethinking False Positive Exercise Electrocardiographic Stress Tests by Assessing Coronary Microvascular Function

Aish Sinha  1 , Utkarsh Dutta  2 , Ozan M Demir  2 , Kalpa De Silva  2 , Howard Ellis  2 , Samuel Belford  2 , Mark Ogden  2 , Matthew Li Kam Wa  2 , Holly P Morgan  2 , Ajay M Shah  2 , Amedeo Chiribiri  2 , Andrew J Webb  2 , Michael Marber  2 , Haseeb Rahman  3 , Divaka Perera  4
Affiliations

Rethinking False Positive Exercise Electrocardiographic Stress Tests by Assessing Coronary Microvascular Function

Aish Sinha et al. J Am Coll Cardiol. .

Abstract

Background: Exercise electrocardiographic stress testing (EST) has historically been validated against the demonstration of obstructive coronary artery disease. However, myocardial ischemia can occur because of coronary microvascular dysfunction (CMD) in the absence of obstructive coronary artery disease.

Objectives: The aim of this study was to assess the specificity of EST to detect an ischemic substrate against the reference standard of coronary endothelium-independent and endothelium-dependent microvascular function in patients with angina with nonobstructive coronary arteries (ANOCA).

Methods: Patients with ANOCA underwent invasive coronary physiological assessment using adenosine and acetylcholine. CMD was defined as impaired endothelium-independent and/or endothelium-dependent function. EST was performed using a standard Bruce treadmill protocol, with ischemia defined as the appearance of ≥0.1-mV ST-segment depression 80 ms from the J-point on electrocardiography. The study was powered to detect specificity of ≥91%.

Results: A total of 102 patients were enrolled (65% women, mean age 60 ± 8 years). Thirty-two patients developed ischemia (ischemic group) during EST, whereas 70 patients did not (nonischemic group); both groups were phenotypically similar. Ischemia during EST was 100% specific for CMD. Acetylcholine flow reserve was the strongest predictor of ischemia during exercise. Using endothelium-independent and endothelium-dependent microvascular dysfunction as the reference standard, the false positive rate of EST dropped to 0%.

Conclusions: In patients with ANOCA, ischemia on EST was highly specific of an underlying ischemic substrate. These findings challenge the traditional belief that EST has a high false positive rate.

Keywords: acetylcholine flow reserve; coronary flow reserve; coronary microvascular dysfunction; coronary physiological assessment; exercise stress test; false positive rate.

PubMed Disclaimer

Conflict of interest statement

Funding Support and Author Disclosures This work is supported by grants from the Medical Research Council (MR/T029390/1), the British Heart Foundation (FS/16/49/32320), and the UK National Institute for Health Research (through the Biomedical Research Center award to King’s College London and Guy’s and St. Thomas’ Hospital). Prof Shah is supported by the British Heart Foundation (CH/1999001/11735). The authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Figures

None
Graphical abstract
Figure 1
Figure 1
Consolidated Standards of Reporting Trials Diagram Demonstrating Study Flow This diagram demonstrates the number of patients assessed for eligibility and the reasons for exclusion. Overall, 262 patients with stable angina were assessed for eligibility, of whom 102 were excluded because of nonanginal symptoms or absence of symptoms. A total of 160 patients underwent coronary angiography with physiological assessment, of whom 38 were excluded. A total of 122 patients with comprehensive coronary physiological assessment (in response to both adenosine and acetylcholine [ACh]) underwent the mandated exercise ECG stress test, of whom 102 were included in the final analysis. BBB = bundle branch block; CAD = coronary artery disease; LBBB = left bundle branch block.
Figure 2
Figure 2
Coronary Physiological Assessment Protocol This is our standard clinical protocol that is used in all patients with angina and nonobstructive coronary arteries to identify an ischemic substrate. All patients undergo coronary angiography followed by intravenous (IV) adenosine assessment. Only patients with fractional flow reserve (FFR) >0.80 were included in this study. Coronary flow reserve (CFR) was calculated as the ratio of hyperemic average peak velocity (APV) in response to adenosine (140 μg/kg/min) and resting APV, with a value of <2.5 used to diagnose endothelium-independent microvascular dysfunction. Patients then underwent assessment with intracoronary (IC) acetylcholine (ACh) infusion (18 μg/mL), and ACh flow reserve (AChFR) was calculated as the ratio of volumetric coronary blood flow (CBF) during ACh infusion and CBF during rest. Volumetric CBF, in turn, was calculated as 0.5 × APV × cross-sectional area 5 mm distal to the Doppler sensor. AChFR ≤1.5 was diagnostic of endothelium-dependent microvascular dysfunction. Patients with CFR <2.5 and/or AChFR ≤1.5 were defined as having coronary microvascular dysfunction (CMD).
Central Illustration
Central Illustration
Exercise Electrocardiographic Stress Testing in the Contemporary Era Assessing the specificity of exercise electrocardiographic (ECG) stress testing against the contemporary gold standard of comprehensive coronary physiological assessment.
See this image and copyright information in PMC

Comment in

References

    1. Knuuti J., Wijns W., Saraste A., et al. 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41:407–477. - PubMed
    1. Mileva N., Nagumo S., Mizukami T., et al. Prevalence of coronary microvascular disease and coronary vasospasm in patients with nonobstructive coronary artery disease: systematic review and meta-analysis. J Am Heart Assoc. 2022;11(7) - PMC - PubMed
    1. Perera D., Berry C., Hoole S.P., et al. Invasive coronary physiology in patients with angina and non-obstructive coronary artery disease: a consensus document from the coronary microvascular dysfunction workstream of the British Heart Foundation/National Institute for Health Research Partnership. Heart. 2023;109:88–95. - PMC - PubMed
    1. Rahman H., Ryan M., Lumley M., et al. Coronary microvascular dysfunction is associated with myocardial ischemia and abnormal coronary perfusion during exercise. Circulation. 2019;140:1805–1816. - PMC - PubMed
    1. Rahman H., Demir O.M., Ryan M., et al. Optimal use of vasodilators for diagnosis of microvascular angina in the cardiac catheterization laboratory. Circ Cardiovasc Interv. 2020;13(6) - PMC - PubMed

Publication types